Purpose The aim of this study was to investigate compassion fatigue (CF) and compassion satisfaction (CS) in nursing care providers in COVID‐19 units. Methods A mixed‐method study with 105 nurses. Results 23% of participants reported high CF risk while 77% expressed high to moderate potential for CS. Adequate preparation/education, clear and accountable leadership, and team sharing of feelings, experiences, and responsibilities during the transition in the COVID‐19 unit helped participants to deal with overwhelming anxiety which if unattended could bring about frustration and long‐lasting feelings of powerlessness. Practical Implications In the face of the present and future pandemics, there is a clear need to prepare healthcare organizations and nursing care providers to cope with the emotional content of public health emergencies while protecting themselves and avoid absorbing unmanageable emotions.

This manuscript reports on two very low birth weight premature infants with respiratory distress, receiving parenteral nutrition and broad-spectrum antibiotics for about 3 weeks, who developed Candida albicans sepsis associated with fungal mycoses and endocarditis, despite treatment with Amphotericin B and Caspofungin. On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas. Our observations suggest that the combination of liposomal Amphotericin B with Fluconazole is able to result in complete resolution of cardiac mycetomas in preterm infants.

The anomalies of the umbilical vessels are uncommon, with the exception of a single umbilical artery. We report a term female infant with fetal hydrops, hypertrophic cardiomyopathy, and a four-vessel umbilical cord consisting of two umbilical arteries and two umbilical veins. The presence of two veins in the umbilical cord has been attributed to persistence of both the normal left umbilical vein and the caudal part of the right umbilical vein. This fetal vascular pathology has been reported very rarely and may be associated with increased risk of congenital malformations and adverse perinatal outcome.

Plasma biotin levels were measured by a new, very sensitive radioligand assay, in 47 normal full-term infants, receiving breast milk and/or different formulas, during the first 3 weeks of life. Exclusively breast fed infants and infants fed with a formula containing 11 μg/l biotin had plasma biotin levels of 538 ± 78 and 502 ± 117 ng/l, respectivley, during the 1st week of life, and 321 ± 48 and 503 ± 153 ng/l, respectively, during the 3rd week of life. Infants fed with a formula very high in biotin (300 μg/l) had extremely high plasma biotin levels during the 1st week of life (13,741 ± 659 ng/l) while during the 2nd week of life they showed a tendency towards decreasing plasma biotin levels. These changes of plasma biotin levels during the first weeks of life indicate that the in vivo kinetics of biotin is changing during this period.